Medicine

Epbriv 0.44mg Injection

Eribulin Mesylate (0.44mg) Allopathy

Epbriv 0.44mg Injection is a allopathy containing Eribulin Mesylate (0.44mg), made by Hetero Healthcare Limited. It belongs to the Anti Neoplastics group of medicines. Like most prescription medicines, it works best when every dose is taken on time, exactly as your doctor prescribed - DailyDawa can send a WhatsApp reminder for each dose and alert a family member if one is missed.

Composition
Eribulin Mesylate (0.44mg)
Manufacturer
Hetero Healthcare Limited
Type
Allopathy
Pack size
vial of 2 ml Injection
Therapeutic class
Anti Neoplastics
Chemical class
Synthetic analogue of halichondrin B
Habit forming
No

Uses

Metastatic breast cancer

Common side effects

Anemia (low number of red blood cells)WeaknessHair lossNauseaConstipationDecreased white blood cell countFatiguePeripheral neuropathy (tingling and numbness of feet and hand)

Reference information only - not medical advice. Always follow your doctor’s instructions for what to take and when.

Chat with us